Lehman David Aaron sold $22K of LUNG
Lehman David Aaron (GENERAL COUNSEL) sold 14,594 shares of Pulmonx Corp (LUNG) at $1.54 across 4 trades on 2026-06-01.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest relative to total holdings, likely causing limited price movement.
Market read
A small insider sell with limited market impact; primarily of interest to short-term traders monitoring insider activity.
What to watch
No 10b5-1 plan; could be personal liquidity need rather than confidence shift.
Background
Form 4 disclosures are primary sources for insider transactions and are routinely monitored by traders.
Ticker impact
General Counsel David Aaron sold 14,594 shares for $22,475 in a Form 4 filing.
likely modest pressure as the market prices in the insider sell.
The sale is small relative to holdings and typical for 10b5-1 plans, but insider disposition can prompt short-term selling.
Market effects
Minimal impact on the medical device sector.
US market only, no broader regional effect.
Low relevance globally.
Counterpoint
The sale could be routine and not indicative of company fundamentals.
Key entities
- CompanyPulmonx Corp
Medical device company listed on NYSE under ticker LUNG.
- IndividualDavid Aaron Lehman
General Counsel of Pulmonx, reporting the insider sale.